These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 6365877)
1. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice. Dijkmans BA; Mattie H; Hermans J; van Furth R J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877 [TBL] [Abstract][Full Text] [Related]
2. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro. Dijkmans BA; Vaishnav J; Mattie H J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection. Beale AS; Gisby J J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099 [TBL] [Abstract][Full Text] [Related]
4. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo. Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242 [No Abstract] [Full Text] [Related]
5. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro. Jokipii L; Jokipii AM J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119 [No Abstract] [Full Text] [Related]
6. Scanning electron microscopic examination of Bacteroides fragilis and Gardnerella vaginalis after exposure to concentration gradients of metronidazole and tinidazole. Skarin A; MĂ„rdh PA Scand J Infect Dis Suppl; 1981; 26():54-9. PubMed ID: 6972572 [TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria. Jokipii AM; Jokipii L Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974 [TBL] [Abstract][Full Text] [Related]
8. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli. Brook I; Ledney GD J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005 [TBL] [Abstract][Full Text] [Related]
9. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)]. Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586 [TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes. Brook I J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934 [TBL] [Abstract][Full Text] [Related]
12. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses. Wells CL; Arland LA; Simmons RL; Rotstein OD J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172 [TBL] [Abstract][Full Text] [Related]
13. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice. Dijkmans BA; Vaishnav J; Mattie H Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873 [TBL] [Abstract][Full Text] [Related]
14. Cloning of a Bacteroides fragilis chromosomal determinant coding for 5-nitroimidazole resistance. Haggoud A; Reysset G; Sebald M FEMS Microbiol Lett; 1992 Aug; 74(1):1-5. PubMed ID: 1516803 [TBL] [Abstract][Full Text] [Related]
15. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities. Brook I Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727 [TBL] [Abstract][Full Text] [Related]
16. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model. Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam]. Werner H; Kuchenbecker K; Hammann R Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice. Dijkmans BA; Vaishnav J; Mattie H Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752 [TBL] [Abstract][Full Text] [Related]
20. [Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam]. Werner H; Kuchenbecker K; Hammann R Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6676177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]